Temozolomide as adjuvant treatment newly diagnosed anaplastic astrocytoma without 1p/19q codeletion following surgery and radiotherapy (adults)
Overview
Temozolomide is an oral medicine that works by stopping cancer cells from making deoxyribonucleic acid (DNA), thereby preventing cell growth. It is proposed to be an additional adjuvant treatment option for people with newly-diagnosed anaplastic astrocytoma who have already been treated with surgery and radiotherapy.
NHS England has launched a 30 day consultation on a policy proposition on commissioning the use of temozolomide as adjuvant treatment for adults with newly diagnosed anaplastic astrocytoma without 1p/19q codeletion following surgery and radiotherapy.
Related documents
Audiences
- Academic/professional institutions
- Advocacy or support organisations
- All interested stakeholders
- All NHS England Staff
- All P&I staff
- Allied health professionals
- Area Team directors
- Care Quality Commission
- Care-givers
- Carers
- Charities
- Childcare providers
- Chiropodists/podiatrists
- Clinical Nurse Specialist
- Clinical psychologists
- Clinicians
- Commissioners
- Community groups
- Community healthcare trusts
- Deaneries
- Dental surgeons
- DH third sector strategic partners
- Diagnostic radiographers
- Dietitians
- Directors of public health
- Doctors
- Employee representatives
- Employer representatives
- Foundation trusts
- GP Practices
- GP Practices
- GPs
- Health and Social Care Information Centre
- Health and Wellbeing boards
- Health care assistants
- Health Education England
- Health Protection Agency
- Health visitors
- Healthcare scientists
- Healthwatch (national and local)
- Higher education institutions
- Informatics professionals
- Information professionals
- Information providers
- Local authorities
- Local Government Association
- Managers
- Mental health trusts
- Midwives
- Monitor
- National directors
- National Institute for Health and Care Excellence
- Neonatal and maternity staff
- NHS England Partnership Organisations
- NHS Trust Development Authority
- Nurses
- Occupation therapists
- Ophthalmic practitioners
- Orthopists
- Orthotists
- Paediatric neuropsychologists
- Paramedics
- Patients
- Pharmaceutical Industry
- Pharmacists
- Physiotherapists
- Policy leads
- Practice managers
- Primary care
- Prosthesists
- Receptionists
- Regional directors
- Regulatory bodies
- Responsible officers
- Retailers
- Royal Colleges
- Service providers
- Service users
- Social care providers
- Speech and language therapists
- Strategic clinical networks (SCNs)
- Suppliers
- Therapeutic radiographers
- Trade unions
- Tribunal service
- Voluntary groups
Interests
- Specialised commissioning
Share
Share on Twitter Share on Facebook